Adverse Drug Events Reporting News

 

Adverse Drug Events Reporting Perspective

  • Dapagliflozin: 'Helpful Strategy' for T1D?   Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.
  • CANVAS: Straight Talk Needed on Amputation Risk Can a meta-analysis of two different studies or data from observational studies overcome the clinical concern about the clear-cut amputation risk with canagliflozin seen in the CANVAS trial?
 

Adverse Drug Events Reporting Journal Articles